Compare DV & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DV | ARDX |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2021 | 2014 |
| Metric | DV | ARDX |
|---|---|---|
| Price | $10.81 | $5.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $16.37 | $15.14 |
| AVG Volume (30 Days) | 2.8M | ★ 3.3M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $748,291,000.00 | $2,607,000.00 |
| Revenue This Year | $12.68 | $37.75 |
| Revenue Next Year | $9.75 | $34.24 |
| P/E Ratio | $248.75 | ★ N/A |
| Revenue Growth | ★ 13.92 | N/A |
| 52 Week Low | $7.61 | $3.74 |
| 52 Week High | $16.82 | $8.40 |
| Indicator | DV | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 40.40 |
| Support Level | $10.71 | $5.46 |
| Resistance Level | $11.06 | $6.29 |
| Average True Range (ATR) | 0.40 | 0.31 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 90.32 | 8.59 |
DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.